A patent review of sirtuin activators: an update

Bibliography

• Yang XJ, Seto E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 2008;9:206-18
   PubMed Web of Science ®Google Scholar
• Gray SG, Ekstrom TJ. The human histone deacetylase family. Exp Cell Res 2001;262:75-83
   PubMed Web of Science ®Google Scholar
• Alcain FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Patents 2009;19:403-14
   PubMed Web of Science ®Google Scholar
• Brittain D, Weinmann H, Ottow E. Recent advances in the medicinal chemistry of histone deacetylase inhibitors. Ann Rep Med Chem 2007;42:337-48
   Google Scholar
• Sauve AA, Wolberger C, Schramm VL, The biochemistry of sirtuins. Annu Rev Biochem 2006;75:435-65
   PubMed Web of Science ®Google Scholar
• Imai S, Armstrong CM, Kaeberlein M, Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000;403:795-800
   PubMed Web of Science ®Google Scholar
• Sauve AA. Sirtuin chemical mechanisms. Biochim Biophys Acta 2010;1804:1591-603
   PubMed Web of Science ®Google Scholar
• Du J, Zhou Y, Su X, Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011;334:806-9
   PubMed Web of Science ®Google Scholar
• Voelter-Mahlknecht S, Letzel S, Mahlknecht U. Fluorescence in situ hybridization and chromosomal organization of the human sirtuin 7 gene. Int J Oncol 2006;28:899-908
   Google Scholar
• Vaziri H, Dessain SK, Ng Eaton E, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149-59
   PubMed Web of Science ®Google Scholar
• Ford E, Voit R, Liszt G, Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 2006;20:1075-80
   PubMed Web of Science ®Google Scholar
• North BJ, Marshall BL, Borra MT, The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003;11:437-44
   PubMed Web of Science ®Google Scholar
• Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007;404:1-13
   PubMed Web of Science ®Google Scholar
• Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000;289:2126-8
   PubMed Web of Science ®Google Scholar
• Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci USA 2004;101:15998-6003
   PubMed Web of Science ®Google Scholar
• Boily G, Seifert EL, Bevilacqua L, SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008;3:e1759
   PubMed Web of Science ®Google Scholar
• Imai S, Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 2010;31:212-20
   PubMed Web of Science ®Google Scholar
• Someya S, Yu W, Hallows WC, Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010;143:1-11
   Google Scholar
• Cohen HY, Miller C, Bitterman KJ, Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004;305:390-2
   PubMed Web of Science ®Google Scholar
• Howitz KT, Bitterman KJ, Cohen HY, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191-6
   PubMed Web of Science ®Google Scholar
• Pearson KJ, Baur JA, Lewis KN, Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008;8:157-68
   PubMed Web of Science ®Google Scholar
• Barger JL, Kayo T, Pugh TD, Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp Gerontol 2008;43:859-66
   PubMed Web of Science ®Google Scholar
• Burnett C, Valentini S, Cabreiro F, Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 2011;477:482-5
   PubMed Web of Science ®Google Scholar
• Bauer J, Antosh M, Chang C, Comparative transcriptional profiling identifies takeout as a gene that regulates life span. Aging (Albany NY) 2010;2:298-310
   PubMedGoogle Scholar
• Wang C, Wheeler CT, Alberico T, The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age (Dordr) DOI: 10.1007/s11357-011-9332-3 2011; PMID 22083438
   Google Scholar
• Brunet A, Sweeney LB, Sturgill JF, Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-15
   PubMed Web of Science ®Google Scholar
• Rodgers JT, Lerin C, Haas W, Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-18
   PubMed Web of Science ®Google Scholar
• Yeung F, Hoberg JE, Ramsey CS, Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004;23:2369-80
   PubMed Web of Science ®Google Scholar
• Silva JP, Wahlestedt C. Role of Sirtuin 1 in metabolic regulation. Drug Discov Today 2010;15:781-91
   PubMed Web of Science ®Google Scholar
• Canto C, Jiang LQ, Deshmukh AS, Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010;11:213-19
   PubMed Web of Science ®Google Scholar
• Hallows WC, Yu W, Denu JM. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation. J Biol Chem 2012;287:3850-8
   PubMed Web of Science ®Google Scholar
• Iwabu M, Yamauchi T, Okada-Iwabu M, Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010;464:1313-19
   PubMed Web of Science ®Google Scholar
• Purushotham A, Xu Q, Li X. Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding. FASEB J 2012;26:656-67
   Google Scholar
• Wang RH, Kim HS, Xiao C, Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Invest 2011;121:4477-90
   PubMed Web of Science ®Google Scholar
• Baur JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010;131:261-9
   PubMed Web of Science ®Google Scholar
• Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 2010;5:253-95
   PubMed Web of Science ®Google Scholar
• Civitarese AE, Carling S, Heilbronn LK, Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 2007;4:e76
   PubMed Web of Science ®Google Scholar
• Clark SJ, Falchi M, Olsson B, Association of Sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity. Obesity (Silver Spring) 2012;20:178-85
   PubMed Web of Science ®Google Scholar
• Ramadori G, Lee CE, Bookout AL, Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 2008;28:9989-96
   PubMed Web of Science ®Google Scholar
• Sasaki T, Kim HJ, Kobayashi M, Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology 2010;151:2556-66
   PubMed Web of Science ®Google Scholar
• Ramadori G, Fujikawa T, Fukuda M, SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab 2010;12:78-87
   Google Scholar
• Knight CM, Gutierrez-Juarez R, Lam TK, Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 2011;60:2691-700
   Google Scholar
• Jiang M, Wang J, Fu J, Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 2011;18:153-8
   Google Scholar
• Jeong H, Cohen DE, Cui L, Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med 2011;18:159-65
   Google Scholar
• Rutanen J, Yaluri N, Modi S, SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 2010;59:829-35
   PubMedGoogle Scholar
• Timmers S, Konings E, Bilet L, Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011;14:612-22
   PubMed Web of Science ®Google Scholar
• Swindell WR. Gene expression profiling of long-lived dwarf mice: longevity-associated genes and relationships with diet, gender and aging. BMC Genomics 2007;8:353
   PubMed Web of Science ®Google Scholar
• Weindruch R, Kayo T, Lee CK, Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. J Nutr 2001;131:918S-23S
   PubMed Web of Science ®Google Scholar
• Wood JG, Rogina B, Lavu S, Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004;430:686-9
   PubMed Web of Science ®Google Scholar
• Celotti E, Ferrarini R, Zironi R, Resveratrol content of some wines obtained from dried valpolicella grapes: recioto and amarone. J Chromatogr A 1996;730:47-52
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, Delegge MH, High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004;32:1377-82
   PubMed Web of Science ®Google Scholar
• Vang O, Ahmad N, Baile CA, What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011;6:e19881
   PubMed Web of Science ®Google Scholar
• Barger JL, Kayo T, Vann JM, A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 2008;3:e2264
   PubMed Web of Science ®Google Scholar
• Dsm Ip Assets Bv. Novel use of nutraceutical compositions comprising resveratrol. WO2007042272; 2007
   Google Scholar
• Sirtris Pharma. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders. WO2007008548; 2007
   Google Scholar
• Baur JA, Pearson KJ, Price NL, Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-42
   PubMed Web of Science ®Google Scholar
• Wong RH, Howe PR, Buckley JD, Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 2011;21:851-6
   PubMed Web of Science ®Google Scholar
• Resveratrol Partners Dietary supplement and method of processing same. WO2005099761; 2005
   Google Scholar
• Pilegaard H, Neufer PD. Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc 2004;63:221-6
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray D, Lekli I, Effects of Longevinex (modified resveratrol) on cardioprotection and its mechanisms of action. Can J Physiol Pharmacol 2010;88:1017-25
   Google Scholar
• Juhasz B, Mukherjee S, Das DK. Hormetic response of resveratrol against cardioprotection. Exp Clin Cardiol 2010;15:e134-8
   PubMedGoogle Scholar
• Juhasz B, Das DK, Kertesz A, Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]. Mol Cell Biochem 2011;348:199-203
   PubMed Web of Science ®Google Scholar
• Fujitaka K, Otani H, Jo F, Modified resveratrol longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res 2011;31:842-7
   PubMed Web of Science ®Google Scholar
• Sirtris Pharma. Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders. WO2007008548; 2007
   Google Scholar
• Smith JJ, Kenney RD, Gagne DJ, Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst Biol 2009;3:31
   Google Scholar
• Howells LM, Berry DP, Elliott PJ, Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases–safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 2011;4:1419-25
   PubMed Web of Science ®Google Scholar
• Available from: Http://Www.Fiercebiotech.Com/Story/Weak-Efficacy-Renal-Risks-Force-Gsk-Dump-Resveratrol-Program/2010-12-01#Ixzz1f6apohzc [Accessed 30 November 2011]
   Google Scholar
• Bemis JE, Vu CB, Xie R, Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators. Bioorg Med Chem Lett 2009;19:2350-3
   PubMed Web of Science ®Google Scholar
• Milne JC, Lambert PD, Schenk S, Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007;450:712-16
   PubMed Web of Science ®Google Scholar
• Vu CB, Bemis JE, Disch JS, Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. J Med Chem 2009;52:1275-83
   PubMed Web of Science ®Google Scholar
• Feige JN, Lagouge M, Canto C, Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008;8:347-58
   PubMed Web of Science ®Google Scholar
• Sirtris Pharma. Sirtuin modulating compounds. US8044198; 2009
   Google Scholar
• Funk JA, Odejinmi S, Schnellmann RG. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J Pharmacol Exp Ther 2010;333:593-601
   Google Scholar
• Yamazaki Y, Usui I, Kanatani Y, Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. Am J Physiol Endocrinol Metab 2009;297:E1179-86
   Google Scholar
• Minor RK, Baur JA, Gomes AP, SRT1720 suppresses apoptosis and restores a more normal gene expression profile indicative of reduced inflammation in the livers of mice fed a high-fat diet. Sci Rep 2011;1:10- 1038/srep00070
   Google Scholar
• Chauhan D, Bandi M, Singh AV, Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells. Br J Haematol 2011;155:588-98
   Google Scholar
• Sirtirs Pharma. Oxazolopyridine derivatives as SIRTUIN modulators. CN101316853; 2008
   Google Scholar
• Sirtris Pharma. Imidazo [2, 1-b] thiazole derivatives as sirtuin modulating compounds. WO2007019344; 2007
   Google Scholar
• Van Der Meer A, Scicluna B, Lin J, The first demonstration of clinical activity by a small molecule sirt1 activator: srt2104 reduces cytokine release and coagulation activation in a human endotoxemia model. 10th World Congress on Inflammation; Paris; 2011
   Google Scholar
• Mai A, Valente S, Meade S, Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J Med Chem 2009;52:5496-504
   PubMed Web of Science ®Google Scholar
• Qin W, Yang T, Ho L, Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 2006;281:21745-54
   PubMed Web of Science ®Google Scholar
• Yang T, Chan NY, Sauve AA. Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J Med Chem 2007;50:6458-61
   Google Scholar
• Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005;280:17187-95
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, Mcdonagh T, Heltweg B, Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005;280:17038-45
   PubMed Web of Science ®Google Scholar
• Beher D, Wu J, Cumine S, Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des 2009;74:619-24
   PubMed Web of Science ®Google Scholar
• Huber JL, Mcburney MW, Distefano PS, SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183. Future Med Chem 2010;2:1751-9
   Google Scholar
• Pacholec M, Bleasdale JE, Chrunyk B, SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010;285:8340-51
   PubMed Web of Science ®Google Scholar
• Cen Y, Youn DY, Sauve AA. Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications. Curr Med Chem 2011;18:1919-35
   PubMed Web of Science ®Google Scholar
• Dai H, Kustigian L, Carney D, SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem 2010;285:32695-703
   PubMed Web of Science ®Google Scholar
• Kim EJ, Kho JH, Kang MR, Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 2007;28:277-90
   PubMed Web of Science ®Google Scholar
• Autiero I, Costantini S, Colonna G. Human sirt-1: molecular modeling and structure-function relationships of an unordered protein. PLoS One 2009;4:e7350
   Google Scholar
• Auld DS, Lovell S, Thorne N, Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci USA 2010;107:4878-83
   PubMed Web of Science ®Google Scholar
• Sirtris Pharma. Sirtuin activators and activation assays. WO2011130595; 2011
   Google Scholar
• Cornell Univ. Activation and activators of SIRT5. WO2011081942; 2011
   Google Scholar
• Smith BC, Hallows WC, Denu JM. A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. Anal Biochem 2009;394:101-9
   PubMed Web of Science ®Google Scholar
• Feng Y, Wu J, Chen L, A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide. Anal Biochem 2009;395:205-10
   PubMed Web of Science ®Google Scholar
• Csiszar A, Labinskyy N, Podlutsky A, Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol 2008;294:H2721-35
   PubMed Web of Science ®Google Scholar
• Um JH, Park SJ, Kang H, AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010;59:554-63
   PubMed Web of Science ®Google Scholar
• Park SJ, Ahmad F, Philp A, Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012;148:421-33
   PubMed Web of Science ®Google Scholar
• Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 2004;279:50754-63
   PubMed Web of Science ®Google Scholar